GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 84 filers reported holding GENERATION BIO CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,463,113 | -30.7% | 913,750 | +0.6% | 0.00% | – |
| Q2 2023 | $4,997,922 | +29.6% | 908,713 | +1.3% | 0.00% | – |
| Q1 2023 | $3,856,008 | -47.0% | 896,746 | -51.5% | 0.00% | – |
| Q4 2022 | $7,268,928 | +49.0% | 1,849,600 | +101.4% | 0.00% | – |
| Q3 2022 | $4,877,000 | -18.7% | 918,491 | +0.4% | 0.00% | – |
| Q2 2022 | $6,002,000 | -4.8% | 914,928 | +6.5% | 0.00% | – |
| Q1 2022 | $6,305,000 | -54.3% | 858,936 | -55.9% | 0.00% | -100.0% |
| Q4 2021 | $13,791,000 | -69.7% | 1,947,909 | +7.5% | 0.00% | -50.0% |
| Q3 2021 | $45,441,000 | -24.7% | 1,812,552 | -19.2% | 0.00% | -33.3% |
| Q2 2021 | $60,369,000 | +0.4% | 2,244,201 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $60,125,000 | +297.1% | 2,112,627 | +295.6% | 0.00% | +200.0% |
| Q4 2020 | $15,140,000 | +239.8% | 534,056 | +270.5% | 0.00% | – |
| Q3 2020 | $4,456,000 | – | 144,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |